DIFFERENTIATION OF HUMAN GERM CELL TUMOR CELLS IN VIVO AND IN VITRO

Three in vitro human germ cell tumor cell lines with different cell lineage and variable capability of differentiation were established from testicular germ cell tumors. NCR-G1 corresponding to yolk sac tumor were induced α-fetoprotein (AFP) production with retinoic acid (RA) treatment. NCR-G2 and -G3 were human embryonal carcinoma (EC) cell lines. They have cytological and immuno-phenotypic characteristics common to human EC cells as has been described in other EC cells. NCR-G2 grew as floating cell aggregates in the culture medium, whereas NCR-G3 grew as floating cell aggregate and flattered cells attached to the surface of culture dish. These flattened cells of NCR-G3 immunohistochemically expressed a variety of differentiation antigens including myogenic markers, extraembryonic trophoblastic cell marker (human chorionic gonadotropin (hCG)), and extracellular proteins. Differentiation capabilities of NCR-G3 cells became more evident when they were treated with RA. By flowcytometric analysis, human EC cell surface markers 2D7, 2H2 and 5D4 which were mouse monoclonal antibodies we obtained from immunization by NCR-G2 cells, disappeared from cell surface of RA-treated NCR-G3 cells. Consistent with these findings, the flattened cells of NCR-G3 that attached to the culture dish were negative for these antibodies. Moreover, longer exposure to RA enhanced hCG production in exposure time dependent fashion. These observations clearly indicate that NCR-G3 possess multipotent differentiation capabilities and they differentiated into the trophoblastic cell lineage other than somatic cells. In contrast to NCR-G3, NCR-G2 did not show any differentiation capabilities with RA treatment. All three germ cell tumor lines produced tumors in athymic mice with 100% efficiency. High AFP content was observed in the sera of NCR-G1 tumor-bearing mice. High hCG and AFP contents were detected in the sera of the NCR-G3 tumor-bearing mice. Thus, our newly established human germ cell tumor cell lines add new insights of molecular mechanism of human embryogenesis and differentiation of EC cells.

[1]  T. F. Rinke de Wit,et al.  Monoclonal antibodies to human embryonal carcinoma cells: antigenic relationships of germ cell tumors. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[2]  P. Andrews,et al.  Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR). , 1990, Differentiation; research in biological diversity.

[3]  C. Taylor,et al.  Alterations of cellular characteristics of a human ovarian teratocarcinoma cell line after in vitro treatment with retinoids. , 1990, Differentiation; research in biological diversity.

[4]  M. Pera,et al.  Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. , 1989, Differentiation; research in biological diversity.

[5]  E. Ishii,et al.  Transplantability and Differentiating Capacity of Human Germ Cell Tumors in Nude Mice , 1989 .

[6]  M. Mason,et al.  Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. , 1988, Differentiation; research in biological diversity.

[7]  S. Hirohashi,et al.  Four new human germ cell tumor cell lines. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[8]  E. Ishii,et al.  Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related. , 1988, Hybridoma.

[9]  山上 正彦 非白血病患者骨髄中に存在するCommon Acute Lymphoblastic Leukemia Antigen(CALLA)陽性リンパ球様細胞の性状に関する研究 , 1988 .

[10]  E. Soini,et al.  Time-Resolved Fluoroimmunoassay , 1988 .

[11]  Y. Ueyama,et al.  Differentiation antigens defined by mouse monoclonal antibodies against human germ cell tumors. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[12]  M. Pera,et al.  Cultured stem‐cells from human testicular teratomas: The nature of human embryonal carcinoma, and its comparison with two types of yolk‐sac carcinoma , 1987, International journal of cancer.

[13]  T. Yamamoto,et al.  HUMAN TESTICULAR GERM CELL TUMORS IN VITRO and IN ATHYMIC NUDE MICE , 1987, Acta pathologica japonica.

[14]  R. Vessella,et al.  A human embryonal—yolk sac carcinoma model system in athymic mice , 1985, Cancer.

[15]  N. Suzuki,et al.  Characterization of human embryonal carcinoma cell lines derived from testicular germ-cell tumors. , 1985, Differentiation; research in biological diversity.

[16]  N C Dracopoli,et al.  Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[17]  P. Lange,et al.  Immunohistochemical localization of placental-like alkaline phosphatase in testis and germ-cell tumors using monoclonal antibodies. , 1983, The American journal of pathology.

[18]  P. Andrews,et al.  Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. , 1983, Cancer research.

[19]  R. Clayman,et al.  Human Testicular Germ Cell Tumors In Vitro , 1983 .

[20]  D. Solter,et al.  Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells , 1982, Cell.

[21]  D. Solter,et al.  Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. , 1982, The American journal of pathology.

[22]  P. Brûlet,et al.  Monoclonal Antibodies as a Tool for the Study of Embryonic Development , 1981 .

[23]  S. Strickland Mouse teratocarcinoma cells: Prospects for the study of embryogenesis and neoplasia , 1981, Cell.

[24]  Y. Ueyama,et al.  Human yolk sac tumor serially transplanted in nude mice: Its morphologic and functional properties , 1980, Cancer.

[25]  G. Martin,et al.  Teratocarcinomas and mammalian embryogenesis. , 1980, Science.

[26]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[27]  K. Illmensee,et al.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Martin,et al.  Teratocarcinomas as a model system for the study of embryogenesis and neoplasia , 1975, Cell.